Pharmacists – Required Notification and Authorized Substitution – Lower–Cost Drug or Device Product
What this bill does
Requiring a pharmacist, or the pharmacist's designee who is under certain supervision, to inform a certain consumer of the availability of certain therapeutically equivalent drugs and the cost difference between the therapeutically equivalent drug and a certain prescribed drug; altering the cost difference of which a pharmacist, or the pharmacist's designee is required to inform a retail consumer under certain circumstances; requiring that a certain determination be based on a consumer's prescription benefit and formulary; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (13)
MGA witness list| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Lockliar, Cailey | MD Retailers Association | Oral |
| FAV | Downey, Ann Marie | Maryland Retired School Personnel Association | Oral + Written (PDF) |
| FAV | Delegate Shetty, Delegate Shettylegislator | Individual | Oral + Written (PDF) |
| FAV | Delong, Michael | Individual | Written (PDF) |
| FAV | Lee, Dr. Kristen | Individual | Oral + Written (PDF) |
| UNF | Wise, Steve | MedChi | Written (PDF) |
| UNF | White, Joshlobbyist | PhRMA | Written (PDF) |
| FWA | Clark, Brad | Board of Pharmacy | Oral + Written (PDF) |
| FWA | Rivkin, Deborahlobbyist | CareFirst | Oral |
| FWA | Taylor, Allisonlobbyist | Kaiser Permanente | Written (PDF) |
| FWA | Horton, Aliyahlobbyist | MD Pharmacists | Oral |
| FWA | Fesche, Camillelobbyist | RWL for PCMA | Oral |
| FWA | Johansen, Mike | RWL for PCMA | Oral |